Skip to main content

Personal Decision Support System For Heart Failure Management

Objective

1–2% of the developed world suffers from congestive heart failure (CHF), which is the most frequent cause of hospitalization in people aged over 65. CHF management involves medications, monitoring of fluid intake and weight, exercise and lifestyle modifications. Since most patients are elderly and suffer from co-morbidities, they have difficulty adhering to the management guidelines, which often leads to poor outcomes.

The HeartMan project will develop a personal health system to help CHF patients manage their disease. Its core will be a decision support system that will provide personalised advice to the patients. Its first key feature will be evidence-based predictive models: a short-term model developed in the European project Chiron, and long-term models adapted to focus on modifiable parameters that can improve the patients' predicted outcomes. Its second key feature will be the delivery of the advice through a cognitive behavioural therapy based on cognitive dissonance. This is a proven approach that exploits the dissonance between healthy attitudes and unhealthy behaviours to improve the behaviours. It will be augmented by mindfulness exercises, which are expected to make the patients more receptive to the HeartMan's advice. The system will also feature advanced health devices and monitoring methods to understand the patients' physical and psychological state, and standard-based data management for wide interoperability.

In developing the HeartMan system, a human-centred approach will be used. The resulting system will be validated in two trials, which will test its medical effectiveness and usability. The project will also have strong dissemination and exploitation. To ensure industry-standard robustness, the industrial partners will have key role in developing the prototypes, and the documentation necessary for certification as a medical device will be prepared. All the consortium will be involved in IPR management and the building of business models.

Field of science

  • /social sciences/economics and business/business and management/business model
  • /medical and health sciences/basic medicine/pharmacology and pharmacy/pharmaceutical drug
  • /social sciences/economics and business

Call for proposal

H2020-PHC-2015-single-stage
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

INSTITUT JOZEF STEFAN
Address
Jamova 39
1000 Ljubljana
Slovenia
Activity type
Research Organisations
EU contribution
€ 477 625

Participants (8)

UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA
Italy
EU contribution
€ 317 375
Address
Piazzale Aldo Moro 5
00185 Roma
Activity type
Higher or Secondary Education Establishments
UNIVERSITEIT GENT
Belgium
EU contribution
€ 475 725
Address
Sint Pietersnieuwstraat 25
9000 Gent
Activity type
Higher or Secondary Education Establishments
CONSIGLIO NAZIONALE DELLE RICERCHE
Italy
EU contribution
€ 422 500
Address
Piazzale Aldo Moro 7
00185 Roma
Activity type
Research Organisations
ATOS SPAIN SA
Spain
EU contribution
€ 413 125
Address
Calle De Albarracin 25
28037 Madrid
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
SENLAB DRUZBA ZA INFORMACIJSKO TEHNOLOGIJO DOO
Slovenia
EU contribution
€ 289 375
Address
Reska Ulica 13
1000 Ljubljana
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium
EU contribution
€ 341 250
Address
Oude Markt 13
3000 Leuven
Activity type
Higher or Secondary Education Establishments
BITTIUM BIOSIGNALS OY
Finland
EU contribution
€ 492 750
Address
Pioneerinkatu 6
70800 Kuopio
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EUROPEAN HEART NETWORK AISBL
Belgium
EU contribution
€ 95 325
Address
Rue Montoyer 31
1000 Bruxelles
Activity type
Other